申请人:Astra Lakemedel Aktiebolag
公开号:US03996381A1
公开(公告)日:1976-12-07
Compounds having the general formula ##STR1## or pharmaceutically acceptable salts thereof, in which formula R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R.sup.3 represents a lower alkyl group or a benzyl group, R.sup.4 represents a hydrogen atom, a lower alkyl group, a benzyl group or a CH.sub.2 CH.sub.2 CH.sub.2 --bridge connected to the phenyl ring in ortho-position relative to the N-substituent, R.sup.5 represents a hydrogen atom or a methyl group and R.sup.6 represents a lower alkyl group, provided that R.sup.1 and/or R.sup.2 represents a lower alkyl group or a halogen atom when R.sup.3 represents a methyl group, R.sup.4 represents a methyl group and R.sup.5 represents a hydrogen atom; methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of depressive states and alleviating anxiety.
具有一般式##STR1##或其药学上可接受的盐的化合物,其中式中R.sup.1和R.sup.2相同或不同,分别表示氢原子,较低烷基或卤素原子,R.sup.3表示较低烷基或苄基,R.sup.4表示氢原子,较低烷基,苄基或连接到邻位相对于N取代基的苯环的CH.sub.2 CH.sub.2 CH.sub.2 --桥,R.sup.5表示氢原子或甲基,R.sup.6表示较低烷基,前提是当R.sup.3表示甲基,R.sup.4表示甲基且R.sup.5表示氢原子时,R.sup.1和/或R.sup.2表示较低烷基或卤素原子;其制备方法;用于制备它们的中间体;包含至少其中一种化合物的制药制剂;以及在治疗抑郁状态和缓解焦虑方面的用途。